DEEPSEEK
ChatGPT Enhances Shopping with New Research Feature
OpenAI introduces a new shopping research feature in ChatGPT, offering personalized product recommendations and comparisons by leveraging user preferences and extensive online resources.
OpenAI Enhances Global Data Residency for ChatGPT and API Users
OpenAI expands data residency options for ChatGPT Enterprise, ChatGPT Edu, and API Platform, allowing customers to store data locally in various global regions, enhancing compliance with local regulations.
GPT-5's Role in Accelerating Scientific Discoveries Explored
OpenAI's GPT-5 is aiding scientific progress by accelerating research workflows and enabling novel discoveries across various fields, according to OpenAI's recent findings.
OpenAI Launches GPT-5.1, Enhancing Developer Tools and Efficiency
OpenAI introduces GPT-5.1, offering faster adaptive reasoning, improved coding performance, and new tools for developers. This upgrade aims to enhance efficiency in various agentic and coding tasks.
OpenAI's GPT-5.1 Launches in Harvey with Enhanced Features
OpenAI's GPT-5.1 is now available in Harvey, offering improved dynamic thinking and better-structured outputs, ideal for legal and strategic applications.
OpenAI Enhances GPT-5 for Sensitive Conversations with New Safety Measures
OpenAI has released an addendum to the GPT-5 system card, showcasing improvements in handling sensitive conversations with enhanced safety benchmarks.
OpenAI Launches New ChatGPT Apps and SDK for Developers
OpenAI introduces new conversational app features and Apps SDK, enhancing ChatGPT's interactive capabilities for users and developers worldwide.
OpenAI Introduces ChatGPT Atlas to Challenge Google Chrome
OpenAI launches ChatGPT Atlas, an AI-driven browser, challenging Google Chrome's dominance with features like real-time data analysis and autonomous task execution.
ChatGPT Creator Valued at $500B, Exceeds SpaceX Record
OpenAI has reached a valuation of $500 billion, now the most valuable private company in the world, exceeding SpaceX.